デフォルト表紙
市場調査レポート
商品コード
1076022

細胞分離の世界市場:2022年~2027年

Cell Isolation/Cell Separation Market - Forecast(2022 - 2027)

出版日: | 発行: IndustryARC | ページ情報: 英文 110 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
細胞分離の世界市場:2022年~2027年
出版日: 2022年04月23日
発行: IndustryARC
ページ情報: 英文 110 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

細胞分離の市場規模は予測期間中17.61%のCAGRで推移し、2027年には144億米ドルの規模に成長すると予測されています。地域別で見ると、北米地域が2019年に最大の収益シェアを示し、予測期間中も市場をリードすると予測されています。

当レポートでは、世界の細胞分離の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 細胞分離市場:市場概要

第2章 細胞分離市場:エグゼクティブサマリー

第3章 細胞分離市場:比較分析

  • 主要企業の製品ベンチマーキング
  • 主要企業の財務分析
  • 主要企業の市場規模の内訳
  • 主要企業の特許分析
  • 価格分析

第4章 細胞分離市場:市場影響因子

  • 市場促進要因
  • 市場抑制要因・課題
  • ポーターのファイブフォースモデル

第5章 細胞分離市場:戦略的分析

  • バリューチェーン分析
  • 市場機会の分析
  • 市場ライフサイクル

第6章 細胞分離市場:製品タイプ別

  • 消耗品
    • 試薬
    • ビーズ
    • 使い捨て品
    • その他
  • 機器
    • 遠心分離機
    • フローサイトメーター
    • ろ過システム
    • 磁気活性化セルセパレーターシステム

第7章 細胞分離市場:細胞別

  • ヒト細胞
  • 動物細胞

第8章 細胞分離市場:技術別

  • ろ過ベース
  • 遠心分離ベース
  • 表面メーカーベース

第9章 細胞分離市場:用途別

  • 幹細胞研究
  • 癌研究
  • 生体分子研究
  • インビトロ診断
  • 組織再生
  • その他

第10章 細胞分離市場:地域別

  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第11章 細胞分離市場:エントロピー

第12章 細胞分離市場:企業分析

目次
Product Code: HCR 1218

Cell Isolation Market size is estimated to reach $14.4Bn by 2027, growing at a CAGR of 17.61% during the forecast period 2022-2027. Cell Isolation is a process of separating individual living cells from a solid block of tissue or cell suspension. Some type of cells naturally exist in a separated form and others are found in solid tissue form, which requires specific techniques to separate them into individual cells. are the factors that are set to drive the growth of the global market for the forecast period 2022-2027.

Cell Isolation Market Report Coverage

The report: "Cell Isolation Market Forecast (2022-2027)", by Industry ARC, covers an in-depth analysis of the following segments of the Cell Isolation Market.

By Product Type: Consumables and Instruments.

By Cell: Human Cell and Animal Cell.

By Technique: Filtration Based Cell Isolation, Centrifugation Based Cell Isolation and Surface Maker Based Cell Isolation.

By Application: Stem Cell Research, Cancer Research, Biomolecule Research, Vitro Diagnostics, Tissue Regeneration, Others.

By Geography: North America, Asia-Pacific, Europe, Rest of World (RoW).

Key Takeaways

Geographically, North America Cell Isolation Market accounted for the highest revenue share in 2019 and it is poised to dominate during the forecast period 2022-2027 owing to the high demand.

The increase in the technology and awareness among customers is likely to aid in the market growth of Cell Isolation Market.

Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Cell Isolation Market report.

The increase in the number of chronic diseases and increase in the demand for laboratory automation are creating higher opportunities for the growth of market for the forecast period 2022-2027.

By Service Type- Segment Analysis

Based on the Service Type, the Repair and Maintenance segment held the largest share in 2019 owing to the factors such as rapid increase in the use of laboratory equipment for research activities and increase in the investment by the public and the private companies. Calibration segment is estimated to be the fastest growing segment during the forecast period 2022-2027. The growth in this segment is owing to the factors such as growing need for accurate and precise information, growing consciousness among customers and the government regulations.

By End User- Segment Analysis

Based on the End User, the Clinical and Diagnostic Laboratories segment held the largest share in 2019 owing to the factors such as rapid increase in the research in drug discovery by the major companies, rapid increase in the number of diseases and growing awareness regarding health. Pharmaceutical and Biotechnological Companies segment is estimated to be the fastest growing segment owing to the factors such as increase in the demand for long-term treatment for chronic diseases, growing healthcare financial products and increase in the demand for generics market.

By Geography - Segment Analysis

Based on the Geography, North America held the largest share in 2019. The growth in this segment is owing to the factors such as advancements in technology, rapid growth in the healthcare infrastructure and government policies supporting the developments in healthcare. Asia-Pacific is estimated to be the fastest growing segment owing to the factors such, as rapid increase in the import of laboratory equipment, investment by the major companies in the developing nations and growing research in pharmaceutical companies.

Drivers - Cell Isolation Market

Rapid increase in the research activities in the pharmaceutical and biotechnological industries.

The increase in the research activities in the pharmaceutical and biotechnological industries owing to rapid increase in the number of diseases, well developed infrastructures and advancements in technology is estimated to enhance the growth of Cell Isolation Market. The increase in the demand for laboratory automation is also estimated to enhance the growth of Cell Isolation Market.

Government's policies to enhance biomedical research activities.

There is a rapid increase in the initiatives and policies by the governments towards biomedical research activities owing to growing awareness among customers increase in the number of aging population and growing prevalence of chronic diseases. This led to rapid increase in the growth of Cell Isolation Market. Investments in the biotechnology sector and improvement in the healthcare infrastructure is also estimated to enhance the growth of the Cell Isolation Market.

Challenges - Cell Isolation Market

The shift from lab-based diagnosis to home-based testing and high cost associated with the service contracts and raw material.

The shift from lab-based diagnosis to home-based testing owing to increase in the awareness among customers, decreasing the chances of complications and advancements in technology is estimated to reduce the growth of the Cell Isolation Market. High costs associated with the service contracts and raw material is also said to reduce the growth of the Cell Isolation Market.

Cell Isolation Industry outlook:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Cell Isolation Market. Key companies of this market are Agilent Technologies, Danaher Corporation, Pace Analytical Services, Thermo Fisher Scientific Inc, PerkinElmer Inc, Waters Corporation, Eppendorf AG, Siemens Healthineers, Abbott Laboratories, Bio-Rad Laboratories Inc among others.

Acquisitions/Product Launches:

In 2020, Agilent Technologies has launched CrossLab Connect Services for Lab-wide Asset Monitoring, which is an advanced service for laboratories seeking increased visibility and control over operations.

In 2020, Waters Corporation has launched the Waters ARC HPLC System to help laboratories meet quality and production targets and for routine testing in the pharmaceutical, food, academic and materials market.

Table of Contents

1. Cell Isolation/Cell Separation Market - Overview

  • 1.1 Definitions and Scope

2. Cell Isolation/Cell Separation Market - Executive Summary

  • 2.1 Market Revenue and Key Trends by Company
  • 2.2 Key trends by Product Type
  • 2.3 Key trends by Technique
  • 2.4 Key trends by Application
  • 2.5 Key trends by Geography

3. Cell Isolation/Cell Separation Market - Comparative Analysis

  • 3.1 Product Benchmarking - Key Companies
  • 3.2 Financial Analysis - Key Companies
  • 3.3 Market Value Split by Key Companies
  • 3.4 Patent Analysis - Key Companies
  • 3.5 Pricing Analysis

4. Cell Isolation/Cell Separation - Market Forces

  • 4.1 Market Drivers
  • 4.2 Market Constraints/Challenges
  • 4.3 Porters five force model
    • 4.3.1 Bargaining power of suppliers
    • 4.3.2 Bargaining powers of customers
    • 4.3.3 Threat of new entrants
    • 4.3.4 Rivalry among existing players
    • 4.3.5 Threat of substitutes

5. Cell Isolation/Cell Separation Market - Strategic Analysis

  • 5.1 Value Chain Analysis
  • 5.2 Opportunities Analysis
  • 5.3 Market Life Cycle

6. Cell Isolation/Cell Separation Market - By Product Type (Market Size -$Million/$Billion)

  • 6.1 Consumables
    • 6.1.1 Reagents
    • 6.1.2 Beads
    • 6.1.3 Disposables
    • 6.1.4 Others
  • 6.2 Instruments
    • 6.2.1 Centrifuges
    • 6.2.2 Flow Cytometers
    • 6.2.3 Filtration Systems
    • 6.2.4 Magnetic-Activated Cell Separator Systems

7. Cell Isolation/Cell Separation Market - By Cell (Market Size -$Million/$Billion)

  • 7.1 Human Cell
  • 7.2 Animal Cell

8. Cell Isolation/Cell Separation Market - By Technique (Market Size -$Million/$Billion)

  • 8.1 Filtration Based Cell Isolation/Cell Separation
  • 8.2 Centrifugation-Based Cell Isolation/Cell Separation
  • 8.3 Surface-Maker Based Cell Isolation/Cell Separation

9. Cell Isolation/Cell Separation Market - By Application (Market Size -$Million/$Billion)

  • 9.1 Stem Cell Research
  • 9.2 Cancer Research
  • 9.3 Biomolecule Research
  • 9.4 VitroDiagnostics
  • 9.5 Tissue Regeneration
  • 9.6 Others

10. Cell Isolation/Cell Separation Market - By Geography (Market Size -$Million/$Billion)

  • 10.1 North America
    • 10.1.1 U.S.
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 U.K.
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Rest of Europe
  • 10.3 Asia-Pacific
    • 10.3.1 China
    • 10.3.2 India
    • 10.3.3 Japan
    • 10.3.4 South Korea
    • 10.3.5 Australia & New Zealand
    • 10.3.6 Rest of Asia-Pacific
  • 10.4 Rest of the World
    • 10.4.1 Middle East
    • 10.4.2 Africa
    • 10.4.3 South America

11. Cell Isolation/Cell Separation Market - Entropy

12. Cell Isolation/Cell Separation Market Company Analysis

  • 12.1 Company 1
  • 12.2 Company 2
  • 12.3 Company 3
  • 12.4 Company 4
  • 12.5 Company 5
  • 12.6 Company 6
  • 12.7 Company 7
  • 12.8 Company 8
  • 12.9 Company 9
  • 12.10 Company 10

"*Financials for private companies would be provided on a best efforts basis".